DECISION Masterclass 2022 - Overview of the effects of LMWH in cirrhosis (Agustín Albillos Martínez)

<p>https://decision-for-liver.eu/</p> <p>The objective of the DECISION project is to enhance the understanding of the pathophysiology of decompensation of #cirrhosis leading to acute-on-chronic liver failure (#ACLF) or death. This consortium will take advantage of already existing large and clinically well-characterized cohorts to ultimately develop prognostic and response tests and combinatorial therapies tailored to the needs of individual patients to decrease the risk of short-term death. In this masterclass, DECISION consortium member Prof. Dr. Agust&iacute;n Albillos Mart&iacute;nez (Department Head Gastroenterology and Hepatology at &quot;Ram&oacute;n y Cajal&quot; Hospital &amp; Professor of Medicine at the University of Alcal&aacute;), provided an overview of the effects of low molecular weight #heparin (#LMWH) in #cirrhosis. In his lecture, he gave a brief refresher on the mode of action of anti-coagulants, followed by the pathophysiological basis for the long-term use of #anticoagulation in cirrhosis as well as the experience with anticoagulants in the clinic. This project has received funding from the European Union&rsquo;s Horizon 2020 research and innovation programme under grant agreement No 847949. This video reflects only the presenter&#39;s view and the European Commission is not responsible for any use that may be made of the information it contains.</p> <p>Video recording: Dr. Ameli Schwalber</p> <p>Video production: Tassilo Steinmann &amp; Dr. Nina Donner</p> <p>Video subtitles: Nicolas Lupke &amp; Tamara Breitinger</p> <p>https://concentris.de &copy; 2023 DECISION</p>